The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,020
Self-citationThe Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Self-citationPepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Stubbs, S. L. J., Brazier, J. S., O’Neill, G. L., & Duerden, B. I. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.461-463.1999 · Cited by 547
(1957) · The Lancet · doi:10.1016/s0140-6736(57)91352-1 · Cited by 391
Barbut, F., Mastrantonio, P., Delmée, M., Brazier, J., Kuijper, E., & Poxton, I. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01824.x · Cited by 297
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Self-citationCrook, D. W., Walker, A. S., Kean, Y., Weiss, K., Cornely, O. A., Miller, M. A., Esposito, R., Louie, T. J., Stoesser, N. E., Young, B. C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis499 · Cited by 260
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Baines, S. D., O'Connor, R., Freeman, J., Fawley, W. N., Harmanus, C., Mastrantonio, P., Kuijper, E. J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn313 · Cited by 247
Self-citationHecht, D. W., Galang, M. A., Sambol, S. P., Osmolski, J. R., Johnson, S., & Gerding, D. N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-06 · Cited by 228
Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
O'Connor, J. R., Galang, M. A., Sambol, S. P., Hecht, D. W., Vedantam, G., Gerding, D. N., & Johnson, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-08 · Cited by 187
Evolutionary History of the Clostridium difficile Pathogenicity Locus
Dingle, K. E., Elliott, B., Robinson, E., Griffiths, D., Eyre, D. W., Stoesser, N., Vaughan, A., Golubchik, T., Fawley, W. N., Wilcox, M. H., et al. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evt204 · Cited by 185
Self-citationCurry, S. R., Marsh, J. W., Shutt, K. A., Muto, C. A., O’Leary, M. M., Saul, M. I., Pasculle, A. W., & Harrison, L. H. (2009) · Clinical Infectious Diseases · doi:10.1086/596315 · Cited by 156
Gonzales, M., Pépin, J., Frost, E. H., Carrier, J. C., Sirard, S., Fortier, L., & Valiquette, L. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-363 · Cited by 133
In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria
Finegold, S. M., Molitoris, D. R., Väisänen, M., Song, Y., Liu, C., & Bolaňos, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4898-4902.2004 · Cited by 122
In Vitro Activity of OPT-80 against Clostridium difficile
Ackermann, G., Löffler, B., Adler, D., & Rodloff, A. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2280-2282.2004 · Cited by 110
Clostridium difficileIsolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018
Spigaglia, P., Barbanti, F., Dionisi, A. M., & Mastrantonio, P. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02482-09 · Cited by 93
Pirš, T., Avberšek, J., Zdovc, I., Krt, B., Andlovic, A., Lejko-Zupanc, T., Rupnik, M., & Ocepek, M. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.058875-0 · Cited by 66
Karlowsky, J. A., Laing, N. M., & Zhanel, G. G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00476-08 · Cited by 62
Miller, M. A., Blanchette, R., Spigaglia, P., Barbanti, F., & Mastrantonio, P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05100-11 · Cited by 39
Cited by
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Self-citationvan Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640
Self-citationUnderstanding Clostridium difficile Colonization
Crobach, M. J. T., Vernon, J. J., Loo, V. G., Kong, L. Y., Péchiné, S., Wilcox, M. H., & Kuijper, E. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-17 · Cited by 318
Self-citationDiversity and Evolution in the Genome of Clostridium difficile
Knight, D. R., Elliott, B., Chang, B. J., Perkins, T. T., & Riley, T. V. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00127-14 · Cited by 286
Peng, Z., Jin, D., Kim, H. B., Stratton, C. W., Wu, B., Tang, Y.-W., & Sun, X. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02250-16 · Cited by 259
Metadata
- Authors
- Freeman, J., Vernon, J., Morris, K., Nicholson, S., Todhunter, S., Longshaw, C., & Wilcox, M. H.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 21
- Issue
- 3
- Pages
- 248.e9-248.e16
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1511476399
- Cited by
- 279
- References
- 22
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.